Abstract
Pneumonia is one of the common complications of SARS-CoV-2 infection where most patients have moderate to severe symptoms that pose a higher risk for death. This study aims to evaluate the treatment outcome of COVID-19-associated Pneumonia among patients with/without comorbidity in a public hospital in Indonesia. This is a retrospective cohort study involving unvaccinated confirmed COVID-19 patients admitted to the hospital between March and December 2020. All confirmed COVID-19 patients with Pneumonia (n = 1522) treated at the hospital were included. The majority of patients (99%) had mild COVID-19 symptoms while the remaining had moderate symptoms. The median age was about 32 years old and the average treatment duration was 6.25 ± 1.83 days. Most patients (88.8%) received a combination of azithromycin and oseltamivir. There was a very significant relationship (p < 0.001) between comorbidities with treatment and duration of treatment of Pneumonia in COVID-19 patients. Although most patients had Pneumonia and comorbidities, they were successfully treated with azithromycin and oseltamivir combination following approximately five days of treatment.
Subject
Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology
Reference44 articles.
1. Coronavirus Disease 2019 (COVID-19) Situation Report—76https://pers.droneemprit.id/covid19/
2. Awas! WHO Akhirnya Tetapkan Corona Darurat Globalhttps://www.cnbcindonesia.com/news/20200131060856-4-134146/awas-who-
3. SOSIALISASI KEARIFAN LOKAL MASYARAKAT BADUY DALAM MITIGASI BENCANA DI PERBATASAN WILAYAH BADUY
4. Project Yourself and Your Familly the Corona Virus—COVID-19www.kemkes.go.id
5. Treatment Protokol COVID-19;Burhan,2020
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献